Judging process
Judging Process
Judging Process
Judging Process
Entrants are asked to complete and submit the Entry Form by email no later than 17.00 GMT 22 January 2026
Each entrant must provide their answer to each criterion in their category in no more than 100 words per criterion
After the closing date, the entries will be circulated to each member of the judging panel for independent scoring.
The top three entries in each category will be shortlisted and announced by 17.00 GMT 09 February 2026
Each finalist will be gifted a complimentary invitation to the Awards Dinner to be held in London on the evening of 19 March 2026
On the evening, there will be presentation of two finalists’ and one winner’s award trophy per category.
JUDGING PANEL FOR 2026
Will Arends, Chartered (UK) and European Patent Attorney | UPC Representative, Marks & Clerk
Caroline Austin, VP, Head of Transactions, Business Development, AstraZeneca
Simon Bradbury, Partner & Patent Attorney, Withers & Rogers LLP
Rachel Bradley, Partner – IP IT & Commercial, Penningtons Manches Cooper
Francesca Crawford, Portfolio NED, F.E.C. Bio
Hayley French, CEO, Domainex
Ro Gardner, Consultant COO & One Nucleus Board member
Eva Haas, Managing Director, Optimum Strategic Communications
Stuart Hendry, CEO, HecoAnalytics & One Nucleus Board member
Jennifer Laird, VP, Search & Evaluation Business
Development | Neuroscience | Lilly Research Labs
Anne Lane, CEO, UCL Business
Melanie Leveridge, Vice President Assays, Profiling & Cell Sciences, BioPharma R&D, AstraZeneca & One Nucleus Board member
Priya Mande, RNAvate
Ricky Martin, CEO, Hyper Recruitment Solutions
Anji Miller, Senior Partner, Academic Engagement/ Programme Director, Translational Fellowships, LifeArc
Judit Molnar, EVP Translational Development at NeoPhore & One Nucleus Board member
Alan Palmer, CE, Elixa Mediscience & One Nucleus Board member
Renos Savva, Head of Innovation and Venture Development, Discovery Park
Catherine Stace, Executive Vice President Business Development, Kuano
Madeleine Wakeling, COO, Harness Therapeutics